Objective To investigate the high-risk factors that may affect the cardiac contractility reserve (CCR) of high-risk pregnant women in the third trimester, and to evaluate the value of the phonocardiogram test (PCGT) in assessment of CCR of pregnant women in the third trimester.
Methods From May 1, 2013 to July 31, 2013, a total of 65 cases of high-risk pregnant women with CCR abnormalities in the third trimester (28-41+ 6 weeks of gestation) in Chengdu Women′s and Children′s Central Hospital were selected as research subjects and included in study group. Simultaneously, others 489 cases of normal CCR pregnant women in the third trimester (28-41+ 6 gestational weeks) during the same period and in the same hospital were selected as control and included in control group. PCGT were used to measure CCR-related indicators, including heart rate, ratio of the amplitude of the first heart sound to the second heart sound (S1/S2), ratio of diastolic to systolic duration (D/S), and ratio of S1 amplitude at tricuspid valve auscultation area to that at mitral auscultation area (T1/M1). Through questionnaires and medical history taking, 14 factors that might affect CCR-related indicators between two groups of pregnant women were collected, and multivariate unconditional logistic regression analysis was performed to analyze the high-risk factors that might affect the CCR of pregnant women in the third trimester. The consistency of CCR indexes S1/S2, D/S and echocardiographic detection of cardiac ejection fraction (EF) and electrocardiogram results in diagnosis of cardiac function in pregnant women in the third trimester were analyzed. This study was in line with the requirements of World Medical Association Declaration of Helsinki revised in 2013. All participants confirmed and signed consent forms for clinical trials.
Results ①Combined with high-risk pregnancies, combined with family history of cardiovascular and cerebrovascular diseases, ≥29-35 years old, ≥35 years old, systolic blood pressure ≥140-160 mmHg (1 mmHg=0.133 kPa) and systolic blood pressure ≥160 mmHg were independent risk factors for abnormal heart rate (OR=3.158, 1.816, 1.760, 1.901, 6.066, 17.055, 95%CI: 1.555-6.415, 1.156-2.853, 1.046-2.960, 1.132-3.194, 1.131-32.548, 2.353-123.599, P=0.001, 0.010, 0.033, 0.015, 0.035, 0.005). Junior college and above education levels of pregnant women was an independent protective factor for heart rate (OR=0.529, 95%CI: 0.321-0.870, P=0.012). ②With 32-34+ 6 gestational weeks, combined with high-risk pregnancy, and systolic blood pressure ≥140-160 mmHg, systolic blood pressure≥160 mmHg were independent risk factors for abnormal S1/S2 (OR=2.400, 5.842, 4.293, 12.875, 95%CI: 1.265-4.553, 2.966-11.506, 1.460-26.467, 2.496-113.852, P=0.007, 0.028, 0.035, 0.005). ③Combined with high-risk pregnancy, diastolic blood pressure ≥90-110 mmHg and diastolic blood pressure ≥110 mmHg were independent risk factors for abnormal D/S (OR=4.706, 1.993, 6.458, 95%CI: 2.556-8.665, 1.532-17.708, 2.391-28.166, P=0.020, 0.010, 0.047). ④Gravidity≥4 times was an independent risk factor for abnormal T1/M1 (OR=9.555, 95%CI: 1.147-77.955, P=0.037). ⑤Among 65 cases of abnormal CCR pregnant women in the third trimester(study group), the coincidence rates of S1/S2 with cardiac EF and routine electrocardiogram results in diagnosis of cardiac function in pregnant women in the third trimester were 93.8% (61/65) and 89.2% (58/65), respectively. And the coincidence rates of D/S with these two examination results were the same as S1/S2.
Conclusions Multiple pregnancies, 32-34+ 6 gestational weeks, combined with high-risk pregnancies, combined with family history of cardiovascular and cerebrovascular diseases, ≥29 years old, systolic blood pressure ≥140 mmHg, and diastolic blood pressure ≥90 mmHg are risk factors for abnormal CCR in pregnant women in the third trimester. We should strengthen the prenatal care for these pregnant women. The consistency rates of CCR indexes with echocardiography(EF) and routine electrocardiogram results are high, and PCGT has the advantages of easy to operation and low cost in assessment of CCR in pregnant women in the third trimester, and can be used to screen the CCR of these pregnant women.